US Demands Up To $3.35B From Novartis In FCA Suit
The government is seeking up to $3.35 billion in a False Claims Act suit accusing Novartis Pharmaceutical Corp. of paying illegal kickbacks to pharmacies to recommend iron-reduction drug Exjade and transplant...To view the full article, register now.
Already a subscriber? Click here to view full article